This article is more than 5 years old. Information may no longer be current.
The 5 most popular items of June
Click Here to Manage Email Alerts
Spine Surgery Today has put together a compilation of the five news stories and videos most viewed from June to keep you abreast of the current hot topics in spine surgery.
Chances of accurate lumbar spinal stenosis diagnosis increase when key questions are asked
SAN FRANCISCO — An International Delphi Study conducted by The International Taskforce on Diagnosis and Management of Lumbar Spinal Stenosis recently identified key questions to ask when getting a patient’s history that may help clinicians more accurately diagnose lumbar spinal stenosis. Read more.
Interlaminar stabilization a sustainable treatment for vertebral motion segment after decompression
According to the results of a recently published study, interlaminar stabilization may provide improved clinical outcomes, safety and radiographic outcomes at 48 months postoperatively compared with posterolateral fusion with pedicle screw fixation after decompression for spinal stenosis. Read more.
Score developed to identify SI joint dysfunction, mitigate need for injection
SAN FRANCISCO — A simple, nine-point sacroiliac joint score developed by investigators from Japan may help distinguish sacroiliac joint dysfunction, which can affect the back, buttocks, groin and lower extremities, from lumbar spine disorders without the need for sacroiliac injection. Read more.
Link possible between running, swimming and lumbar disc degeneration
SAN FRANCISCO — Intense swimming and running at a younger age was associated with more lumbar disc degeneration later on among young Finnish adults, according to results of a study presented here. Read more.
Interspinous spacer for lumbar stenosis likely not inferior to existing device
SAN FRANCISCO — An interspinous device designed to treat patients with lumbar spinal stenosis implanted using a minimally invasive technique was associated with good clinical results at short-term follow-up, according to findings from a prospective, randomized, multicenter FDA investigational device exemption (IDE) trial presented here at the International Society for the Study of the Lumbar Spine Annual Meeting. Read more.